Prenetics Global (NASDAQ:PRE) Given Overweight Rating at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Prenetics Global (NASDAQ:PRE) in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a $9.00 price objective on the stock.

Prenetics Global Trading Down 1.2 %

Shares of PRE opened at $5.93 on Thursday. Prenetics Global has a fifty-two week low of $2.85 and a fifty-two week high of $7.84. The stock has a fifty day moving average of $5.19 and a two-hundred day moving average of $5.09.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.